🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dárrel P. Francis

Imperial College Healthcare NHS Trust

ORCID: 0000-0002-3410-0814

Also affiliated with Lung Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial”.

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

The Lancet(2024)10.1016/s0140-6736(24)00256-3

N/A

3.1DataRank · unranked

85 citations

Christopher Rajkumar, Fiyyaz Ahmed‐Jushuf, Florentina Simader, Shayna Chotai, Rachel Pathimagaraj +25 more

Improving the Design of Future PCI Trials for Stable Coronary Artery Disease

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.05.060

N/A

0DataRank · unranked

9 citations

David J. Moliterno, Dárrel P. Francis, Peter Jüni, Yves Rosenberg, Bimmer E. Claessen +8 more

Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

European Heart Journal - Quality of Care and Clinical Outcomes(2021)10.1093/ehjqcco/qcab072

N/A

0DataRank · unranked

23 citations

Mahesh V. Madhavan, Gregg W. Stone, Dárrel P. Francis, Raj Makkar, Deepak L. Bhatt +2 more

Why Do I Get Side Effects? Personalized (N-of-1) Trials for Statin Intolerance and the Nocebo Effect

PubMed(2022)10.1162/99608f92.abc57f1b

N/A

0DataRank · unranked

3 citations

Frances A. Wood, Dárrel P. Francis, James P. Howard